These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32150561)

  • 1. The epidemiology of Hepatitis B, C and D in Germany: A scoping review.
    Steffen G; Sperle I; Leendertz SA; Sarma N; Beermann S; Thamm R; Bremer V; Zimmermann R; Dudareva S
    PLoS One; 2020; 15(3):e0229166. PubMed ID: 32150561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping Review.
    Sperle I; Steffen G; Leendertz SA; Sarma N; Beermann S; Thamm R; Simeonova Y; Cornberg M; Wedemeyer H; Bremer V; Zimmermann R; Dudareva S
    Front Public Health; 2020; 8():424. PubMed ID: 33014960
    [No Abstract]   [Full Text] [Related]  

  • 3. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
    Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
    J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccination coverage in Germany: systematic review.
    Steffen G; Sperle I; Harder T; Sarma N; Beermann S; Thamm R; Bremer V; Zimmermann R; Dudareva S
    BMC Infect Dis; 2021 Aug; 21(1):817. PubMed ID: 34391406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of hepatitis B, C and D in Malawi: systematic review.
    Stockdale AJ; Mitambo C; Everett D; Geretti AM; Gordon MA
    BMC Infect Dis; 2018 Oct; 18(1):516. PubMed ID: 30314448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
    Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
    BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania.
    Voiculescu M; Iliescu L; Ionescu C; Micu L; Ismail G; Zilisteanu D; Radasan A; Micu G; Pertache I
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):43-8. PubMed ID: 20361074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population.
    Chen F; Zhang J; Guo F; Wen B; Luo S; Yuan D; Lin Y; Ou W; Tang P; Dai G; Li F; Liu W; Qu X
    J Gastroenterol Hepatol; 2017 Feb; 32(2):515-520. PubMed ID: 27248508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B, C, and D virus and human T-cell leukemia virus types 1 and 2 infections and correlates among men who have sex with men in Ouagadougou, Burkina Faso.
    Ouedraogo HG; Kouanda S; Grosso A; Compaoré R; Camara M; Dabire C; Ouedraogo R; Traore Y; Baral S; Barro N
    Virol J; 2018 Dec; 15(1):194. PubMed ID: 30594218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of infections by hepatitis B, C, D and E viruses in Bolivia].
    León P; Venegas E; Bengoechea L; Rojas E; López JA; Elola C; Echevarría JM
    Rev Panam Salud Publica; 1999 Mar; 5(3):144-51. PubMed ID: 10355311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How to assess the elimination of viral hepatitis B, C, and D in Germany? Outcomes of an interdisciplinary workshop].
    Zimmermann R; Külper-Schiek W; Steffen G; Gillesberg Lassen S; Bremer V; Dudareva S;
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Jan; 64(1):77-90. PubMed ID: 33326051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hepatitis B, C, and D virus infection in Haiti: A systematic review and meta-analysis.
    Vincent JP; Nyamasege C; Wang S; Madec Y; Shimakawa Y
    Front Public Health; 2022; 10():1099571. PubMed ID: 36711383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual risk of infection with blood-borne viruses in potential organ donors at increased risk of infection: systematic review and meta-analysis.
    Waller KM; De La Mata NL; Kelly PJ; Ramachandran V; Rawlinson WD; Wyburn KR; Webster AC
    Med J Aust; 2019 Nov; 211(9):414-420. PubMed ID: 31489635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B (HBV), hepatitis C (HCV) and hepatitis delta (HDV) viruses in the Colombian population--how is the epidemiological situation?
    Alvarado-Mora MV; Fernandez MF; Gomes-Gouvêa MS; de Azevedo Neto RS; Carrilho FJ; Pinho JR
    PLoS One; 2011 Apr; 6(4):e18888. PubMed ID: 21559488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing hepatitis B vaccination coverage and decreasing hepatitis B co-infection prevalence among people with HIV-1 in Germany, 1996-2019. Results from a cohort study primarily in men who have sex with men.
    Krings A; Schmidt D; Kollan C; Meixenberger K; Bannert N; Münstermann D; Tiemann C; Bremer V; Gunsenheimer-Bartmeyer B;
    HIV Med; 2024 Feb; 25(2):201-211. PubMed ID: 37786263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic overview of hepatitis C infection in the Middle East and North Africa.
    Chaabna K; Cheema S; Abraham A; Alrouh H; Lowenfels AB; Maisonneuve P; Mamtani R
    World J Gastroenterol; 2018 Jul; 24(27):3038-3054. PubMed ID: 30038471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection.
    Roggenbach I; Chi X; Lempp FA; Qu B; Walter L; Wu R; Gao X; Schnitzler P; Ding Y; Urban S; Niu J
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.